Blood cancers

Should you prescribe anti-CD20 maintenance therapy?

Should the treating clinician prescribe anti-CD20 maintenance drugs like rituximab in patients with CLL? The answer is: it depends, says Melbourne leukaemia expert Dr Constantine Tam. Writing in an editorial published in The Lancet Haematology,  Dr Tam from St Vincent’s Hospital and the Peter MacCallum Cancer Centre said  several factors had to be considered when deciding ...

Already a member?

Login to keep reading.

© 2021 the limbic